2025-04-14 03:54:39
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
CRISIL Ltd Q1CY21 consolidated PAT lower at Rs. 83.52 crores
Posted On : 2021-04-19 20:50:21( TIMEZONE : IST )
CRISIL LTD. has reported financial results for the period ended March 31, 2021.
Financial Results (Q1 CY2021) - QoQ Comparison
The company has reported total income of Rs.508.65 crores during the period ended March 31, 2021 (Q1 CY2021) as compared to Rs.612.22 crores during the period ended December 31, 2020 (Q4 CY2020).
The company has posted net profit of Rs.83.52 crores for the period ended March 31, 2021 as against Rs.110.04 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.11.49 for the period ended March 31, 2021 as compared to Rs.15.14 for the period ended December 31, 2020.
| Financials | Q1 CY2021 | Q4 CY2020 | % Change |
| Total Income | ₹ 508.65 crs | ₹ 612.22 crs |  -16.92% |
| Net Profit | ₹ 83.52 crs | ₹ 110.04 crs | -24.1% |
| EPS | ₹ 11.49 | ₹ 15.14 | -24.11% |
Financial Results (Q1 CY2021) - YoY Comparison
The company has reported total income of Rs.508.65 crores during the period ended March 31, 2021 (Q1 CY2021) as compared to Rs.458.15 crores during the period ended March 31, 2019 (Q1 CY2020).
The company has posted net profit of Rs.83.52 crores for the period ended March 31, 2021 as against Rs.88.12 crores for the period ended March 31, 2019.
The company has reported EPS of Rs.11.49 for the period ended March 31, 2021 as compared to Rs.12.16 for the period ended March 31, 2019.
| Financials | Q1 CY2021 | Q1 CY2020 | % Change |
| Total Income | ₹ 508.65 crs | ₹ 458.15 crs | 11.02% |
| Net Profit | ₹ 83.52 crs | ₹ 88.12 crs | -5.22% |
| EPS | ₹ 11.49 | ₹ 12.16 | -5.51% |
Says Ashu Suyash, Managing Director & CEO, CRISIL, "During the quarter, we saw good business momentum across Ratings, Research and Analytics. Buoyant capital markets and new client acquisitions aided growth. Ongoing demand for traded and credit-risk offerings also helped. We continue to make investments in data and technology capabilities, and in ensuring that our people are able to navigate well through the pandemic and serve clients."
Shares of CRISIL LTD. was last trading in BSE at Rs.1897 as compared to the previous close of Rs. 1872.75. The total number of shares traded during the day was 5618 in over 1231 trades.
The stock hit an intraday high of Rs. 1920 and intraday low of 1790. The net turnover during the day was Rs. 10557879.
